Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aion Therapeutic Inc C.AION

Alternate Symbol(s):  ANTCF

Aion Therapeutic Inc is in the business of research and development, treatment, data mining and state-of-the-art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery.


CSE:AION - Post by User

Post by moneynorthboundon Jan 15, 2021 12:02pm
149 Views
Post# 32306394

AION IS SO PIPED FOR IMMINENT NEWSWIRE WE ARE SO DO!

AION IS SO PIPED FOR IMMINENT NEWSWIRE WE ARE SO DO!LAST NR was Dec 23...LOOK just how informed AION kept their investors in all past history. That confirms my canary that BIG CHANGES are being made here! The boardroom table is stacked with legal papers to make this change!! Calm before the storm!
ABSOLUTELY, AION is getting ready to give shareholders a newswire. SHHHEEESh even management knows its beeen too long since shareholders update newswire!!!! RIGHT???

Next

Aion Therapeutic Announces Closing of Non-Brokered Private Placement

Newsfile December 23, 2020

Aion Therapeutic Amends Convertible Debentures

Newsfile October 30, 2020

Aion Therapeutic Names James W.G. Thompson, Ph.D. as President

Newsfile October 21, 2020

Aion Therapeutic Announces Closing of Non-Brokered Private Placement

Newsfile September 18, 2020

Aion Therapeutic, Inc. Announces the Appointment of Dr. Herbert Fritsche, Former Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at the University of Texas, MD Anderson Cancer Center in Houston, Texas as Chief Science Officer

Newsfile September 10, 2020

Aion Therapeutic Files Five Patents with the United States Patent and Trademark Office

Newsfile September 3, 2020

Aion Therapeutic's Dr. Stephen D. Barnhill to Present at Microdose "Psychedelic Capital Series" on September 3, 2020

Newsfile August 31, 2020

CSE Bulletin: Name and Symbol Change - Osoyoos Cannabis Inc. (OSO)

Newsfile August 27, 2020

Osoyoos Announces Name Change to "Aion Therapeutic Inc."

Newsfile August 27, 2020

Osoyoos Provides Board Update; Approves Name Change

Newsfile August 19, 2020

Osoyoos Retains Integrity Media for Investor Relations and Corporate Communications

Newsfile August 12, 2020

Osoyoos Announces Results of Annual and Special Meeting

Newsfile August 10, 2020

Osoyoos Closes Non-Brokered Private Placement

Newsfile August 4, 2020

Osoyoos Closes Tranche of Non-Brokered Private Placement

Newsfile July 20, 2020

Osoyoos Provides Corporate Update on AI Pharma Acquisition

Newsfile July 8, 2020

Osoyoos Announces Closing of Acquisition of AI Pharmaceuticals Jamaica Limited

Newsfile June 30, 2020

Osoyoos Announces Agreement to Acquire AI Pharmaceuticals Jamaica Limited

Newsfile June 26, 2020

Osoyoos Announces Non-Brokered Private Placement

Newsfile June 16, 2020

Osoyoos Provides Update on Annual and Special Meeting

Newsfile June 4, 2020

Osoyoos' Extraction Systems Now Commissioned and Approved

Newsfile May 26, 2020
  •  

<< Previous
Bullboard Posts
Next >>